Registration of securities issued in business combination transactions

Note 20 - Stock-based Compensation

v3.24.2.u1
Note 20 - Stock-based Compensation
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 20. Stock-Based compensation

 

For the years ended December 31, 2023 and 2022, stock-based compensation expense recognized in SG&A expenses was approximately $5.4 million and $3.0 million, respectively.

 

Stock Award Plans

 

The Company maintains stock incentive plans to attract, motivate and retain management, key employees, directors, and consultants. These plans provide for discretionary awards of, among others, stock options, stock awards, stock unit awards, and stock appreciation rights to participants (collectively, share-based awards).

 

Restricted Stock Awards

 

The following table summarizes our restricted stock awards activity:

 

   

Number of Units

   

Weighted Average Grant Date Fair Value

 

Outstanding as of December 31, 2021

    867,500     $ 4.20  

Granted

    136,000     $ 2.72  

Vested

    (543,500 )   $ 3.78  

Forfeited

        $  

Outstanding as of December 31, 2022

    460,000     $ 4.32  

Granted

    559,000     $ 1.65  

Vested

    (794,000 )   $ 2.42  

Forfeited

        $  

Outstanding as of December 31, 2023

    225,000     $ 4.33  

 

As of December 31, 2022, there was approximately $2.3 million of net unrecognized compensation cost related to unvested stock-based compensation to be recognized over the remaining weighted average period of 1.40 years.

 

As of December 31, 2023, there was approximately $1.1 million of net unrecognized compensation cost related to unvested stock-based compensation to be recognized over the remaining weighted average period of 1.58 years.

 

Stock Options

 

Stock options outstanding at December 31, 2023 and 2022, as disclosed in the below table, have approximately ($4.4 million) and ($6.1 million) of intrinsic value, respectively.

 

A summary of the status of the Company’s outstanding stock options and changes during the years ended December 31, 2023 and 2022, is as follows:

 

   

Number of Options

   

Weighted Average Exercise Price

   

Weighted Average Grant Date Fair Value

   

Weighted Average Remaining Contractual Life (Years)

 

Balance at January 1, 2022

    2,179,892     $ 4.54     $ 2.44       5.93  

Granted

    190,000     $ 1.92     $ 1.43       6.85  

Exercised

        $     $        

Cancelled

    (250,000 )   $ 5.35     $        

Expired

    (191 )   $     $        

Balance outstanding at December 31, 2022

    2,119,701     $ 4.16     $ 2.25       5.23  
                                 

Options exercisable at December 31, 2022

    1,259,701     $ 3.51     $ 1.68       6.25  
                                 

Balance at January 1, 2023

    2,119,701     $ 4.16     $ 2.25       5.23  

Granted

    395,000     $ 2.37     $ 2.37       4.06  

Exercised

        $     $        

Cancelled

    (266,284 )   $ 5.88     $        

Expired

    (3,084 )   $     $        

Balance outstanding at December 31, 2023

    2,245,333     $ 3.63     $ 2.88       4.26  
                                 

Options exercisable at December 31, 2023

    1,771,997     $ 3.31     $ 2.86       4.63  

 

For the year ended  December 31, 2022, the Company granted 190,000 stock options valued at approximately $1.10 - $1.92 per option, using a Black-Scholes option pricing model with the following assumptions: stock price of $1.71 - $2.20 per share (based on closing price of the Company’s common stock on the date of grant), volatility of 75% - 100%, expected term of 5 to 10 years and a risk free interest rate of 2.66% to 4.39%.

 

For the year ended  December 31, 2023, the Company granted 395,000 stock options valued at approximately $1.98-$2.64 per option, using a Black-Scholes option pricing model with the following assumptions: stock price of $1.98-$2.64 per share (based on closing price of the Company’s common stock on the date of grant), volatility of 502%-504%, expected term of 2-5 years, and a risk free interest rate of 3.31%-3.71%.

 

As of  December 31, 2022, there was approximately $1.4 million of net unrecognized compensation cost related to unvested stock options to be recognized over the remaining weighted average period of  3.73 years.

 

As of December 31, 2023, there was approximately $1.4 million of net unrecognized compensation cost related to unvested stock options to be recognized over the remaining weighted average period of 2.88 years.